Skip Navigation
Grant Details

Grant Number: 5P01CA154292-03 Interpret this number
Primary Investigator: Miglioretti, Diana
Organization: Group Health Cooperative
Project Title: Risk-Based Breast Cancer Screening in Community Settings
Fiscal Year: 2013
Back to top


Abstract

The program theme is to identify effective breast cancer screening strategies for women with diverse levels of breast cancer risk to maximize screening benefits while minimizing potential harms. Program aims follow the premise that breast cancer screening will be most effective when: guidelines are based on accurate risk estimates that are tied to the effectiveness and harms of screening tests; women and physicians are informed about screening test performance based on risk level; risk-based screening practices are equitable; and high-quality comparative effectiveness research results are disseminated into community practice. Program goals will be met through three complementary research projects and three shared resource cores. Project 1, Risk Assessment in Community Practice: Developing Better Models, will improve prediction of breast cancer and breast cancer subtypes among women of varying ages and race/ethnicity and evaluate whether predicted risk can be used to optimize screening outcomes. Project 2, Comparative Effectiveness of Imaging Strategies for Breast Cancer Screening in Community Practice, will characterize the performance of advanced imaging technologies and screening strategies according to age, race/ethnicity, breast density, and overall breast cancer risk. Project 3, Community-based Utilization of Breast Imaging Technologies, will assess risk-based screening in diverse populations and identify disparities in access and use of new technologies. The Administrative Core will support logistical requirements and facilitate communication and data sharing. The Biostatistics and Data Management Core will coordinate data collection, management, and analysis and will develop statistical methods. The Comparative Effectiveness Core will use simulation modeling to estimate long-term implications of different screening practices on population health. The program represents an integrated effort to improve screening with the overall aim of averting deaths from breast cancer while minimizing harms.

Back to top


Publications

Breast MRI BI-RADS Assessments and Abnormal Interpretation Rates by Clinical Indication in US Community Practices.
Authors: Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD
Source: Acad Radiol, 2014 Aug 7;null, p. null.
EPub date: 2014 Aug 7.
PMID: 25126973
Related Citations

Back to top


Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
Authors: Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS
Source: Ann Intern Med, 2014 Jul 15;161(2), p. 104-12.
PMID: 25023249
Related Citations

Back to top


Geographic Access to Breast Imaging for US Women.
Authors: Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN
Source: J Am Coll Radiol, 2014 Sep;11(9), p. 874-82.
EPub date: 2014 Jun 2.
PMID: 24889479
Related Citations

Back to top


Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Authors: Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS
Source: J Natl Cancer Inst, 2014 Jun;106(6), p. dju092.
EPub date: 2014 May 28.
PMID: 24872543
Related Citations

Back to top


First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants.
Authors: Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA, Hurlbert MS, Benz CC
Source: Cancer Causes Control, 2014 Jul;25(7), p. 859-68.
EPub date: 2014 May 7.
PMID: 24801045
Related Citations

Back to top


Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.
Authors: Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL
Source: Breast Cancer Res Treat, 2014 Jun;145(3), p. 765-73.
EPub date: 2014 May 7.
PMID: 24800915
Related Citations

Back to top


Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.
Authors: O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ
Source: Ann Intern Med, 2014 Feb 4;160(3), p. 145.
PMID: 24658691
Related Citations

Back to top


Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies.
Authors: Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA
Source: Breast Cancer Res Treat, 2014 May;145(1), p. 165-75.
EPub date: 2014 Mar 20.
PMID: 24647890
Related Citations

Back to top


Addressing the challenge of assessing physician-level screening performance: mammography as an example.
Authors: Burnside ES, Lin Y, Munoz del Rio A, Pickhardt PJ, Wu Y, Strigel RM, Elezaby MA, Kerr EA, Miglioretti DL
Source: PLoS One, 2014;9(2), p. e89418.
EPub date: 2014 Feb 21.
PMID: 24586763
Related Citations

Back to top


Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Authors: Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS
Source: Breast Cancer Res Treat, 2014 Apr;144(2), p. 405-16.
EPub date: 2014 Feb 21.
PMID: 24557337
Related Citations

Back to top


Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.
Authors: Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G
Source: Am J Epidemiol, 2014 Mar 15;179(6), p. 749-58.
EPub date: 2014 Jan 30.
PMID: 24488511
Related Citations

Back to top


Carrell et al. respond to "Observational research and the EHR".
Authors: Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G
Source: Am J Epidemiol, 2014 Mar 15;179(6), p. 762-3.
EPub date: 2014 Jan 30.
PMID: 24488509
Related Citations

Back to top


Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.
Authors: Wirtz HS, Boudreau DM, Gralow JR, Barlow WE, Gray S, Bowles EJ, Buist DS
Source: Breast Cancer Res Treat, 2014 Feb;143(3), p. 541-50.
EPub date: 2014 Jan 10.
PMID: 24407530
Related Citations

Back to top


Agreement of mammographic measures of volumetric breast density to MRI.
Authors: Wang J, Azziz A, Fan B, Malkov S, Klifa C, Newitt D, Yitta S, Hylton N, Kerlikowske K, Shepherd JA
Source: PLoS One, 2013;8(12), p. e81653.
EPub date: 2013 Dec 4.
PMID: 24324712
Related Citations

Back to top


Investigation of mammographic breast density as a risk factor for ovarian cancer.
Authors: Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS
Source: J Natl Cancer Inst, 2014 Jan;106(1), p. djt341.
EPub date: 2013 Dec 5.
PMID: 24309005
Related Citations

Back to top


Patterns of breast magnetic resonance imaging use in community practice.
Authors: Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC, Breast Cancer Surveillance Consortium
Source: JAMA Intern Med, 2014 Jan;174(1), p. 125-32.
PMID: 24247555
Related Citations

Back to top


Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.
Authors: Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV Jr, Cauley JA, Hue TF, Lacroix A, Falk RT, Pfeiffer RM, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA, B~FIT Research Group
Source: Carcinogenesis, 2014 Feb;35(2), p. 346-55.
EPub date: 2013 Nov 8.
PMID: 24213602
Related Citations

Back to top


Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.
Authors: Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM
Source: Radiology, 2014 Feb;270(2), p. 354-61.
EPub date: 2013 Oct 28.
PMID: 24072778
Related Citations

Back to top


Risk factors for inflammatory breast cancer and other invasive breast cancers.
Authors: Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL
Source: J Natl Cancer Inst, 2013 Sep 18;105(18), p. 1373-84.
PMID: 24046390
Related Citations

Back to top


Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
Authors: O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL
Source: Cancer, 2013 Nov 15;119(22), p. 3959-67.
EPub date: 2013 Aug 26.
PMID: 24037812
Related Citations

Back to top


Frequent antibiotic use and second breast cancer events.
Authors: Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM
Source: Cancer Epidemiol Biomarkers Prev, 2013 Sep;22(9), p. 1588-99.
EPub date: 2013 Jul 5.
PMID: 23833124
Related Citations

Back to top


Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Authors: Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL, Breast Cancer Surveillance Consortium
Source: J Gen Intern Med, 2013 Nov;28(11), p. 1454-62.
EPub date: 2013 Jun 13.
PMID: 23760741
Related Citations

Back to top


Benign breast disease, mammographic breast density, and the risk of breast cancer.
Authors: Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K
Source: J Natl Cancer Inst, 2013 Jul 17;105(14), p. 1043-9.
EPub date: 2013 Jun 6.
PMID: 23744877
Related Citations

Back to top


Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.
Authors: Etzioni R, Gulati R, Mallinger L, Mandelblatt J
Source: Ann Intern Med, 2013 Jun 4;158(11), p. 831-8.
PMID: 23732716
Related Citations

Back to top


To screen or not to screen older women for breast cancer: a conundrum.
Authors: Braithwaite D, Mandelblatt JS, Kerlikowske K
Source: Future Oncol, 2013 Jun;9(6), p. 763-6.
PMID: 23718292
Related Citations

Back to top


Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention.
Authors: Mandelblatt J, van Ravesteyn N, Schechter C, Chang Y, Huang AT, Near AM, de Koning H, Jemal A
Source: Cancer, 2013 Jul 15;119(14), p. 2541-8.
EPub date: 2013 Apr 26.
PMID: 23625540
Related Citations

Back to top


Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study.
Authors: Rauscher GH, Conant EF, Khan JA, Berbaum ML
Source: BMC Cancer, 2013 Apr 26;13, p. 208.
EPub date: 2013 Apr 26.
PMID: 23621946
Related Citations

Back to top


Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Authors: Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES, Breast Cancer Surveillance Consortium
Source: JAMA Intern Med, 2013 May 13;173(9), p. 807-16.
PMID: 23552817
Related Citations

Back to top


Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Authors: Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K, Breast Cancer Surveillance Consortium
Source: J Natl Cancer Inst, 2013 Mar 6;105(5), p. 334-41.
EPub date: 2013 Feb 5.
PMID: 23385442
Related Citations

Back to top


Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control.
Authors: Mandelblatt JS, Tosteson AN, van Ravesteyn NT
Source: JAMA Intern Med, 2013 Feb 11;173(3), p. 227-8.
PMID: 23303388
Related Citations

Back to top


Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.
Authors: Chang Y, Schechter CB, van Ravesteyn NT, Near AM, Heijnsdijk EA, Adams-Campbell L, Levy D, de Koning HJ, Mandelblatt JS
Source: Breast Cancer Res Treat, 2012 Dec;136(3), p. 823-35.
EPub date: 2012 Oct 27.
PMID: 23104221
Related Citations

Back to top